Entities / Company
DAXOR.
Czech company
- Reports this week
- 0
- Active events
- 0
- Connections
- 22
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ days-
DAXOR is expanding into a Tennessee medical center, integrating BVA with on-site analyzer for heart failure services.Some support1 report
-
FDA clearance enables market access for a new device from DAXOR.Some support2 reports
-
Daxor received FDA clearance for its diagnostic and presented findings in New York City.Some support4 reports
-
DAXOR's technology was validated in Jan Bakker's study, and ATR was identified as a measure of fluid leakage technology.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around DAXOR this week
News at the entities that move DAXOR most-
FDA StructuralFDA conducted surprise raids and inspections in Bihar state, directed by state government officials.Moves DAXOR
-
Food and Drug Administration StructuralSummit seeks FDA approval for its drug, which was presented at the ASCO meeting. The company is developing ivonescimab with Akeso.Moves DAXOR
-
New York City Shared contextDSM-Firmenich opens a new flagship location in Chelsea, NYC, while Housing Works participates in an Open Air event.Moves DAXOR
-
Kansas Shared contextThe administration is focusing on deep-red states as national economic concerns and high costs of living drive voter targeting efforts.Moves DAXOR
Connections
The 7 strongest of 22, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
DAXOR's market access and product function are formally dependent on receiving regulatory clearance from the FDA.
-
BVA Structural
Daxor utilizes BVA's technology for volume measurement, establishing a functional dependency.
-
Food and Drug Administration Structural
DAXOR's analyzer requires clearance from the FDA to enable blood volume testing.
-
Duke University Medical Center Structural
Daxor's technology is validated by Duke University Medical Center research, which Daxor then uses in its public announcements.
-
American College of Cardiology Shared context
Daxor presented technology and data at American College of Cardiology events.
-
Kansas Shared context
DAXOR operates within the geographic and regulatory context of Kansas.
-
New York City Shared context
DAXOR operates within the context of New York City, utilizing it as a location for professional conferences.
History
Events by the month they beganOctober 2026
1 eventJune 2026
4 events- DAXOR is expanding into a Tennessee medical center, integrating BVA with on-site analyzer for heart failure services.
- FDA clearance enables market access for a new device from DAXOR.
- Daxor received FDA clearance for its diagnostic and presented findings in New York City.
- DAXOR's technology was validated in Jan Bakker's study, and ATR was identified as a measure of fluid leakage technology.